Apple isn't the biggest winner from Trump's plans for a tax holiday. These three stocks are. ...
Biotech investors should keep a close eye on the progress in this huge potential market.
The FDA action was a win for Pfizer because Xeljanz escapes competition for one year or more.
Doug Kass shares his thoughts on Apple, Allergan and Western Digital.
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.